OptimizeRx Corporation
OPRX
$7.77
$0.628.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.17M | -17.91M | -18.07M | -17.57M | -13.75M |
| Total Depreciation and Amortization | 4.15M | 3.57M | 2.98M | 2.40M | 1.96M |
| Total Amortization of Deferred Charges | 848.10K | 622.10K | 416.10K | 211.10K | -111.50K |
| Total Other Non-Cash Items | 26.22M | 21.20M | 21.91M | 23.26M | 16.07M |
| Change in Net Operating Assets | -8.61M | -9.36M | -12.28M | -15.55M | -2.35M |
| Cash from Operations | -1.57M | -1.88M | -5.04M | -7.24M | 1.82M |
| Capital Expenditure | -100.30K | -115.30K | -90.30K | -87.30K | -98.30K |
| Sale of Property, Plant, and Equipment | 10.00K | 10.00K | 10.00K | 10.00K | -- |
| Cash Acquisitions | -82.95M | -82.95M | -82.95M | -82.95M | 0.00 |
| Divestitures | 2.54M | 2.54M | 2.54M | 2.54M | -- |
| Other Investing Activities | 54.17M | 53.26M | 56.55M | 55.15M | -17.72M |
| Cash from Investing | -26.33M | -27.25M | -23.94M | -25.34M | -17.82M |
| Total Debt Issued | 37.73M | 37.73M | 37.73M | 37.73M | -- |
| Total Debt Repaid | -3.21M | -2.71M | -2.21M | -1.71M | -- |
| Issuance of Common Stock | 15.00K | 16.00K | 121.00K | 161.00K | 169.40K |
| Repurchase of Common Stock | -732.70K | -749.70K | -7.93M | -7.96M | -15.28M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 300.00K | 0.00 | 0.00 | 0.00 | -300.00K |
| Cash from Financing | 34.10M | 34.29M | 27.71M | 28.22M | -15.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 1.00K | 1.00K | 1.00K | 1.00K |
| Net Change in Cash | 6.21M | 5.15M | -1.26M | -4.36M | -31.41M |
